Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,509,442
+$5,138,864 QoQ
Shares Held
579,801
+1.6% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#82
of 646 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. RPRX ranks #2 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97,334 | $48,348,717 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
579,801 | $32,509,442 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
77,161 | $21,988,570 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,166 | $8,779,840 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,665 | $8,520,674 | |
| 6 | ASND |
Ascendis Pharma A/S
|
16,394 | $4,372,607 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $3,057,839 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,509,442 | 579,801 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $27,370,578 | 570,577 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,654,712 | 301,623 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,210,244 | 204,372 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,199,298 | 199,814 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||